Terbinafine hydrochloride, Lamisil, Lamisil, Corbinal, Zabel, Sebifin, Zimig, mycoCeaze, MycoVa

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

93 API Suppliers, 27 USDMF, 24 CEP/COS, 17 JDMF, 10 EU WC, 36 KDMF, 22 NDC API, 24 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

146 FDF Dossiers, 25 FDA Orange Book, 68 Europe, 12 Canada, 15 South Africa, 26 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 1%, SOLUTION;TOPICAL - 1%, GRANULE;ORAL - EQ 125MG BASE/PACKET, GRANULE;ORAL - EQ 187.5MG BASE/PACKET

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 Seqens, 4 DKSH, 3 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 4 Actylis, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 21 BASF, 10 Corel Pharma Chem, 4 DFE Pharma, 2 Esteem Industries, 3 Finar, 8 Gangwal Chemicals, 4 Ideal Cures, 2 Ingredion Pharma Solutions, 16 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 3 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 10 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

42 Coating Systems & Additives, 26 Controlled & Modified Release, 24 Topical, 23 Disintegrants & Superdisintegrants, 23 Fillers, Diluents & Binders, 22 Thickeners and Stabilizers, 17 Solubilizers, 15 Granulation, 14 Lubricants & Glidants, 12 Direct Compression, 12 Emulsifying Agents, 10 Co-Processed Excipients, 6 Taste Masking, 6 Film Formers & Plasticizers, 5 Surfactant & Foaming Agents, 5 Rheology Modifiers, 5 Parenteral, 5 Empty Capsules, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Chewable & Orodispersible Aids, 2 Coloring Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 2 News #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 34 Regulatory FDF Prices

MARKET PLACE

17 APIs

17 APIs

PATENTS & EXCLUSIVITIES

5 Health Canada Patents

5 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20980 / DOSAGE - CREAM;TOPICAL - 1%

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
TERBINAFINE HYDROCHLORIDE(UNII: 012C11ZU6G) (TERBINAFINE - UNII:G7RIW8S0XP)	TERBINAFINE HYDROCHLORIDE	10mg in 1

Inactive Ingredients

Ingredient Name	Cardinal Health	Kaiser Foundation Hospitals	Novartis Consumer Health, Inc.	Preferred Plus (Kinray)	REMEDYREPACK INC.	Rugby Laboratories, Inc.	Strategic Sourcing Services LLC	Target Corporation
BENZYL ALCOHOL(LKG8494WBH)
cetyl alcohol(936JST6JCN)
CETYL PALMITATE(5ZA2S6B08X)
isopropyl myristate(0RE8K4LNJS)
polysorbate 60(CAL22UVI4M)
SODIUM HYDROXIDE(55X04QC32I)
sorbitan monostearate(NVZ4I0H58X)
STEARYL ALCOHOL(2KR89I4H1Y)
WATER(059QF0KO0R)

Drug Product Composition: Terbinafine hydrochloride, Lamisil, Lamisil, Corbinal, Zabel, Sebifin, Zimig, mycoCeaze, MycoVa